These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17015695)
1. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. Yu A; Malek TR J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695 [TBL] [Abstract][Full Text] [Related]
2. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388 [TBL] [Abstract][Full Text] [Related]
7. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565 [TBL] [Abstract][Full Text] [Related]
8. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance. Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807 [TBL] [Abstract][Full Text] [Related]
9. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Malek TR; Yu A; Vincek V; Scibelli P; Kong L Immunity; 2002 Aug; 17(2):167-78. PubMed ID: 12196288 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172 [TBL] [Abstract][Full Text] [Related]
12. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. Vang KB; Yang J; Mahmud SA; Burchill MA; Vegoe AL; Farrar MA J Immunol; 2008 Sep; 181(5):3285-90. PubMed ID: 18714000 [TBL] [Abstract][Full Text] [Related]
13. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Yu A; Zhu L; Altman NH; Malek TR Immunity; 2009 Feb; 30(2):204-17. PubMed ID: 19185518 [TBL] [Abstract][Full Text] [Related]
14. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. Malek TR; Porter BO; Codias EK; Scibelli P; Yu A J Immunol; 2000 Mar; 164(6):2905-14. PubMed ID: 10706676 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression. Simonetta F; Gestermann N; Bloquet S; Bourgeois C PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946 [TBL] [Abstract][Full Text] [Related]
16. A Chimeric IL-7Rα/IL-2Rβ Receptor Promotes the Differentiation of T Cell Progenitors into B Cells and Type 2 Innate Lymphoid Cells. Shimba A; Tani-Ichi S; Masuda K; Cui G; Munakata S; Abe S; Kitano S; Miyachi H; Kawamoto H; Ikuta K J Immunol; 2024 Oct; 213(7):952-964. PubMed ID: 39140896 [TBL] [Abstract][Full Text] [Related]
17. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984 [TBL] [Abstract][Full Text] [Related]
19. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells. Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662 [TBL] [Abstract][Full Text] [Related]
20. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool. Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]